MG
CME icon

Michael Gelband’s CME Group CME Stock Holding History

Michael Gelband’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,736
Closed -$2.63M – 1613
2025
Q3 		$2.63M Sell
9,736
-55,883
-85% -$15.2M 0.03% 636
2025
Q2 		$18.1M Buy
+65,619
New +$17.8M 0.16% 129
2025
Q1 		– Sell
-57,432
Closed -$13.3M – 1527
2024
Q4 		$13.3M Buy
57,432
+24,767
+76% +$5.7M 0.09% 200
2024
Q3 		$7.21M Sell
32,665
-49,204
-60% -$10.2M 0.04% 303
2024
Q2 		$16.1M Buy
81,869
+34,914
+74% +$7.21M 0.11% 161
2024
Q1 		$10.1M Buy
46,955
+15,270
+48% +$3.21M 0.08% 204
2023
Q4 		$6.67M Buy
31,685
+29,521
+1,364% +$6.3M 0.04% 286
2023
Q3 		$433K Sell
2,164
-13,558
-86% -$2.69M ﹤0.01% 1288
2023
Q2 		$2.91M Buy
+15,722
New +$2.91M 0.02% 658
2023
Q1 		– Sell
-129,924
Closed -$21.8M – 1798
2022
Q4 		$21.8M Buy
129,924
+104,798
+417% +$18.2M 0.32% 56
2022
Q3 		$4.45M Buy
25,126
+19,762
+368% +$3.91M 0.06% 448
2022
Q2 		$1.1M Buy
5,364
+2,725
+103% +$578K 0.01% 1040
2022
Q1 		$628K Buy
+2,639
New +$620K 0.01% 1402
2020
Q4 		– Sell
-9,302
Closed -$1.56M – 2011
2020
Q3 		$1.56M Sell
9,302
-7,309
-44% -$1.23M 0.03% 487
2020
Q2 		$2.7M Buy
16,611
+8,605
+107% +$1.54M 0.07% 319
2020
Q1 		$1.38M Sell
8,006
-28,674
-78% -$5.71M 0.08% 240
2019
Q4 		$7.36M Buy
36,680
+31,899
+667% +$6.54M 0.14% 120
2019
Q3 		$1.01M Buy
+4,781
New +$999K 0.04% 392
2019
Q1 		– Sell
-3,925
Closed -$738K – 684
2018
Q4 		$738K Buy
+3,925
New +$725K 0.05% 108

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Michael Gelband's CME Position: Q4 2025 in Review

Michael Gelband sold out of CME Group (CME) in Q4 2025, closing a stake of 9,736 shares — an estimated $2.63M sold.

Michael Gelband first reported a position in CME in Q4 2018 and held it in 19 quarters. The position peaked at $21.8M in Q4 2022. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • Michael Gelband reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
  • Michael Gelband sold 9,736 CME Group shares in Q4 2025, an estimated $2.63M.
  • Michael Gelband first reported a position in CME Group in Q4 2018 and held it in 19 quarters.
  • Michael Gelband's CME Group position peaked at $21.8M in Q4 2022.
  • 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.